生物成分市場規模、佔有率和成長分析（按產品類型、表達系統和地區）- 產業預測 2025-2032

2023 年全球生物基原料市場規模價值 21.9 億美元，預計將從 2024 年的 23.9 億美元成長到 2032 年的 47.6 億美元，預測期內（2025-2032 年）的複合年成長率為 9.0%。

全球生物成分市場正經歷顯著成長，這得益於製藥、農業和食品生產等領域對永續和創新解決方案的需求不斷成長。生物技術，特別是基因工程和合成生物學的最新進展，導致了生物基成分、酵素和化學物質的激增，它們不僅提供了更高的性能，還提供了環境優勢。此外，人們越來越意識到生物基原料在解決資源稀缺和氣候變遷等問題的潛力，這也加速了其應用。儘管如此，監管挑戰和公眾看法將繼續在塑造未來市場動態方面發揮關鍵作用。總體而言，生物基成分的不斷發展和接受度將為市場在各行業的進一步擴張和影響力奠定基礎。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 專利分析

生物成分市場規模（按類型和複合年成長率） (2025-2032)

• 市場概況
• 創新生物技術 API
• 生物相似藥

生物材料市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 單株抗體
• 疫苗
• 荷爾蒙和生長因子
• 細胞激素
• 融合蛋白
• 治療性酵素
• 血液因素

生物材料市場規模（按表達系統和複合年成長率） (2025-2032)

• 市場概況
• 哺乳動物表達系統
• 微生物表現系統
• 酵母表現系統
• 植物表達系統
• 昆蟲表達系統

生物成分市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Novo Nordisk（Denmark）
• BASF（Germany）
• Lonza Group（Switzerland）
• DSM（Netherlands）
• Evonik Industries（Germany）
• WuXi AppTec（China）
• Samsung Biologics（South Korea）
• Biocon（India）
• Dr. Reddy's Laboratories（India）
• Divi's Laboratories（India）
• Laurus Labs（India）
• Concord Biotech（India）
• Amgen（USA）
• Genentech（USA）
• Regeneron Pharmaceuticals（USA）
• Gilead Sciences（USA）
• Celgene（USA）
• Bristol Myers Squibb（USA）
• Sanofi（France）
• GlaxoSmithKline（UK）

結論和建議

Global Biotech Ingredients Market size was valued at USD 2.19 billion in 2023 and is poised to grow from USD 2.39 billion in 2024 to USD 4.76 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The global biotech ingredients market is experiencing significant growth, driven by rising demand for sustainable and innovative solutions across sectors like pharmaceuticals, agriculture, and food production. Recent advancements in biotechnology, particularly genetic engineering and synthetic biology, have led to a surge in bio-based ingredients, enzymes, and chemicals that enhance performance while providing environmental advantages. Moreover, increasing awareness of biotech ingredients' potential to tackle issues such as resource scarcity and climate change is accelerating their adoption. Nonetheless, regulatory challenges and public perception continue to play crucial roles in shaping the market's future dynamics. Overall, the continued evolution and acceptance of biotech ingredients position the market for further expansion and influence in various industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biotech Ingredients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biotech Ingredients Market Segments Analysis

Global Biotech Ingredients Market is segmented by Type, Product, Expression System and region. Based on Type, the market is segmented into Innovative Biotech Apis and Biosimilars. Based on Product, the market is segmented into Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes and Blood Factors. Based on Expression System, the market is segmented into Mammalian Expression Systems, Microbial Expression Systems, Yeast Expression Systems, Plant Expression Systems and Insect Expression Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biotech Ingredients Market

The global biotech ingredients market is significantly propelled by the increasing demand for sustainable and plant-based products. As consumer awareness surrounding health and environmental issues rises, there is a notable trend toward the preference for products enriched with natural and eco-friendly components. Biotechnology enables the production of these ingredients through innovative processes that are both efficient and environmentally sustainable, minimizing the dependence on conventional agricultural practices. This alignment with consumer desires for clean labels and transparency is driving the widespread adoption of biotech ingredients in diverse sectors, including food, cosmetics, and pharmaceuticals, further boosting market growth.

Restraints in the Global Biotech Ingredients Market

The global biotech ingredients market faces notable restraints primarily due to regulatory hurdles and public apprehension regarding genetically modified organisms (GMOs). Although biotechnology has made significant strides, lingering concerns about the safety of GMOs, their potential environmental repercussions, and ethical implications contribute to consumer skepticism and increased scrutiny from regulatory authorities. Stringent regulations and mandatory labeling for products incorporating biotech ingredients can hinder the market's expansion. To navigate these challenges effectively, it is essential for industry participants to pursue transparent communication, undertake thorough safety evaluations, and implement educational initiatives aimed at building consumer trust and dispelling misconceptions surrounding biotech ingredients.

Market Trends of the Global Biotech Ingredients Market

The global biotech ingredients market is experiencing robust growth as it adapts to shifting consumer preferences towards sustainability and natural offerings. This trend is predominantly fueled by an increasing demand for biotech-derived ingredients across diverse sectors such as food, cosmetics, and pharmaceuticals. Innovations in genetic engineering and bioprocessing techniques are paving the way for the development of novel ingredients with enhanced functionalities, thereby broadening application scopes. Supportive regulatory frameworks are bolstering biotech innovation, while strategic collaborations between biotech companies and conventional manufacturers are seamlessly integrating these ingredients into mainstream products. The landscape is increasingly characterized by a pronounced pivot towards bio-based solutions that resonate with environmentally aware consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Patent Analysis

Global Biotech Ingredients Market Size by Type & CAGR (2025-2032)

• Market Overview
• Innovative Biotech Apis
• Biosimilars

Global Biotech Ingredients Market Size by Product & CAGR (2025-2032)

• Market Overview
• Monoclonal Antibodies
• Vaccines
• Hormones and Growth Factors
• Cytokines
• Fusion Proteins
• Therapeutic Enzymes
• Blood Factors

Global Biotech Ingredients Market Size by Expression System & CAGR (2025-2032)

• Market Overview
• Mammalian Expression Systems
• Microbial Expression Systems
• Yeast Expression Systems
• Plant Expression Systems
• Insect Expression Systems

Global Biotech Ingredients Market Size & CAGR (2025-2032)

• North America (Type, Product, Expression System)
  • US
  • Canada
• Europe (Type, Product, Expression System)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Expression System)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Expression System)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Expression System)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evonik Industries (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Biologics (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Divi's Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laurus Labs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Concord Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations